Human Medicine:

SYNLAB launch Faecal Immunochemical Testing (FIT)

Jul 2019 – SYNLAB have announced the launch of Faecal Immunochemical Testing (FIT), a bowel / colorectal cancer screening test.

FIT is a more sensitive screening test which selectively detects the human globin-protein in stool, making it specific to colonic blood loss.

Click here for further information about Faecal Immunochemical Testing (FIT) and other specialised tests offered by SYNLAB in the UK.

Latest Human Medicine News
SYNLAB announce agreement with Arquer Diagnostics for bladder cancer testing

13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…

Read More (about 'SYNLAB announce agreement with Arquer Diagnostics for bladder cancer testing')
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…

Read More (about 'SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation')
Press statement: SYNLAB UK & Ireland confirmed as preferred NHS strategic partner

21 January 2020 SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB…

Read More (about 'Press statement: SYNLAB UK & Ireland confirmed as preferred NHS strategic partner')